939 related articles for article (PubMed ID: 30251332)
1. Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report.
Shen WC; Chang Liao NF; Lin TY; Wu PY
J Cutan Pathol; 2019 Jan; 46(1):62-66. PubMed ID: 30251332
[TBL] [Abstract][Full Text] [Related]
2. A child with both Langerhans and non-Langerhans cell histiocytosis.
Shani-Adir A; Chou P; Morgan E; Mancini AJ
Pediatr Dermatol; 2002; 19(5):419-22. PubMed ID: 12383099
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cell histiocytosis arising from a BCC: a case report and review of the literature.
Patel P; Talpur R; Duvic M
Cutis; 2010 Jun; 85(6):295-300. PubMed ID: 20666189
[TBL] [Abstract][Full Text] [Related]
4. Langerhans' cell histiocytosis: report of a case with temporal localization.
Martini A; Aimoni C; Trevisani M; Marangoni P
Int J Pediatr Otorhinolaryngol; 2000 Sep; 55(1):51-6. PubMed ID: 10996236
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine.
Eckstein OS; Bernhardt MB; Hood CG; Karri V; Kralik SF; McClain KL
Pediatr Hematol Oncol; 2023; 40(5):497-505. PubMed ID: 36625721
[TBL] [Abstract][Full Text] [Related]
7. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Langerhans cell histiocytosis in elderly with chronic myelomonocytic leukemia.
Iwasaki T; Takahashi I; Nagashima T; Igawa S; Komatsu S; Honma M; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2014 Mar; 41(3):262-5. PubMed ID: 24628074
[TBL] [Abstract][Full Text] [Related]
9. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
[TBL] [Abstract][Full Text] [Related]
10. Langerhans cell histiocytosis mimicking malignant melanoma: a diagnostic pitfall.
Billings TL; Barr R; Dyson S
Am J Dermatopathol; 2008 Oct; 30(5):497-9. PubMed ID: 18806499
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod.
O'Kane D; Jenkinson H; Carson J
Clin Exp Dermatol; 2009 Dec; 34(8):e829-32. PubMed ID: 19843082
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic.
Podjasek JO; Loftus CG; Smyrk TC; Wieland CN
Int J Dermatol; 2014 Mar; 53(3):305-11. PubMed ID: 23621577
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
14. Langerhans Cell Histiocytosis Mimicking Periapical Pathology in a 39-year-old Man.
Peters SM; Pastagia J; Yoon AJ; Philipone EM
J Endod; 2017 Nov; 43(11):1909-1914. PubMed ID: 28864216
[TBL] [Abstract][Full Text] [Related]
15. Isolated Langerhans cell histiocytosis of the sublingual gland in an adult.
Yang S; Chen X; Zhang J; Fang Q
Int J Clin Exp Pathol; 2015; 8(10):13647-50. PubMed ID: 26722591
[TBL] [Abstract][Full Text] [Related]
16. Molluscum Contagiosum-Like Presentation of Langerhans Cell Histiocytosis: A Case and Review.
Karpman MS; AlJasser MI; Lam JM
Pediatr Dermatol; 2017 Sep; 34(5):e288-e289. PubMed ID: 28730670
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression.
Goerdt S; Kolde G; Bonsmann G; Hamann K; Czarnetzki B; Andreesen R; Luger T; Sorg C
J Pathol; 1993 Aug; 170(4):421-7. PubMed ID: 7692027
[TBL] [Abstract][Full Text] [Related]
18. Localized Acral Sclerosing Langerhans Cell Histiocytosis: A New Form of Presentation of Cutaneous Langerhans Cell Histiocytosis.
Garrido MC; Salido-Vallejo R; Revilla E; Salvatierra J; Rodriguez-Peralto JL
Am J Dermatopathol; 2020 May; 42(5):356-359. PubMed ID: 31725482
[TBL] [Abstract][Full Text] [Related]
19. Comparison of magnetic resonance imaging with invasive histological findings of Langerhans cell histiocytosis.
Watanabe S; Yamamoto T; Satomi K; Matsuda M; Akutsu H; Ishikawa E; Matsumura A
Brain Tumor Pathol; 2014 Jul; 31(3):182-6. PubMed ID: 24604297
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome: An association not previously described.
Hipólito LN; Mendoza-Cembranos MD; Villaescusa MT; Jo-Velasco M; Requena L; Alegría-Landa V
J Cutan Pathol; 2019 Aug; 46(8):609-612. PubMed ID: 31006900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
